MyAverix Finance
F · Healthcare
BIOCELTIX S.A. ZY -10 (XI3)
Biotechnology
BIOCELTIX S.A. ZY -10 (XI3) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for XI3
BIOCELTIX S.A. ZY -10 (XI3) — FAQ
What is XI3's P/E ratio?
The price-to-earnings (P/E) ratio for BIOCELTIX S.A. ZY -10 (XI3) is 25.00 (data as of 2026-05-23).
Does BIOCELTIX S.A. ZY -10 pay a dividend?
Dividend yield is not available in the current snapshot for BIOCELTIX S.A. ZY -10 (XI3). Check the MyAverix Finance app for the latest dividend data.
What sector is BIOCELTIX S.A. ZY -10 in?
BIOCELTIX S.A. ZY -10 (XI3) is classified in the Healthcare sector (Biotechnology industry).
What exchange is XI3 listed on?
XI3 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.